Published in Gastroenterology on March 01, 2002
Narrow Band Imaging Project on Barrett's Esophagus | NCT01580631
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43
Clinical practice. Gastroesophageal reflux disease. N Engl J Med (2008) 3.30
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol (2010) 2.37
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet (2015) 2.10
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc (2008) 1.96
Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76
Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut (2004) 1.67
The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci (2010) 1.65
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus (2010) 1.42
Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans. Gastrointest Endosc (2014) 1.41
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31
Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.29
What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut (2004) 1.29
Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc (2009) 1.17
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One (2008) 1.12
Screening for Barrett's Esophagus. Gastroenterology (2015) 1.11
Barrett's esophagus and the increasing role of endoluminal therapy. Therap Adv Gastroenterol (2008) 1.11
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS One (2013) 1.08
TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort. Gut (2006) 1.03
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax (2006) 1.02
Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium. Gastroenterology (2015) 1.01
Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2012) 1.01
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. World J Gastroenterol (2003) 1.00
Managing Barrett's oesophagus. BMJ (2003) 0.98
Are screening and surveillance for Barrett's oesophagus really worthwhile? Gut (2005) 0.97
New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. Clin Cancer Res (2011) 0.96
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Br J Cancer (2007) 0.91
The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91
Surveillance in Barrett's esophagus: an audit of practice. Dig Dis Sci (2009) 0.88
Screening and surveillance for Barrett's esophagus: current issues and future directions. Curr Opin Gastroenterol (2012) 0.87
Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87
A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol (2014) 0.85
Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc (2011) 0.85
Inter-Observer Agreement among Pathologists Using Wide-Area Transepithelial Sampling With Computer-Assisted Analysis in Patients With Barrett's Esophagus. Am J Gastroenterol (2015) 0.83
Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments. J Gastrointest Oncol (2012) 0.83
Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) (2013) 0.83
The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol (2017) 0.82
Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia. Gastroenterol Rep (Oxf) (2015) 0.82
MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study. Clin Transl Gastroenterol (2014) 0.80
Chemoprevention of esophageal adenocarcinoma. Therap Adv Gastroenterol (2008) 0.79
Screening for Barrett's esophagus: results from a population-based survey. Dig Dis Sci (2014) 0.79
"Indefinite for Dysplasia" in Barrett's Esophagus: Inflammation and DNA Content Abnormality are Significant Predictors of Early Detection of Neoplasia. Clin Transl Gastroenterol (2015) 0.79
Screening, surveillance, and prevention for esophageal cancer. Gastroenterol Clin North Am (2009) 0.79
Barrett's Esophagus: Emerging Knowledge and Management Strategies. Patholog Res Int (2012) 0.78
Diagnosis and management of Barrett's esophagus. Surg Clin North Am (2012) 0.78
Endoscopic imaging in Barrett's esophagus: current practice and future applications. Ann Gastroenterol (2012) 0.78
A 52-year-old man with heartburn: should he undergo screening for Barrett's esophagus? Clin Gastroenterol Hepatol (2009) 0.78
Endoscopic screening and surveillance for Barrett's esophagus--clinical implications. MedGenMed (2006) 0.78
Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila) (2013) 0.77
Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort. Gastrointest Endosc (2016) 0.77
Era of Barrett's surveillance: does equipment matter? World J Gastroenterol (2010) 0.77
Screening for esophageal luminal narrowing--a magnetic disc tablet as a bolus challenge: preliminary report. Dig Dis Sci (2004) 0.76
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol (2015) 0.76
Advances in the endoscopic diagnosis and treatment of Barrett's neoplasia. F1000Res (2016) 0.76
[Barrett's esophagus: analyses from human and experimental animal studies]. Pathologe (2013) 0.76
Diagnostics and Early Diagnosis of Esophageal Cancer. Viszeralmedizin (2015) 0.75
Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Diagnosis and management of Barrett's metaplasia: What's new. World J Gastrointest Endosc (2012) 0.75
[Does surveillance of patients with Barrett's esophagus improve survival?]. Z Gastroenterol (2003) 0.75
Endoscopic surveillance in Barrett's oesophagus. Gut (2003) 0.75
The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort. United European Gastroenterol J (2016) 0.75
Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer? Therap Adv Gastroenterol (2009) 0.75
Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus. Br J Cancer (2016) 0.75
Endoscopic management of Barrett esophagus. Nat Rev Gastroenterol Hepatol (2011) 0.75
Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability. Endosc Int Open (2016) 0.75
Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus. Dig Dis Sci (2014) 0.75
Current surveillance and therapeutic options for barrett esophagus. Gastroenterol Hepatol (N Y) (2008) 0.75
Barrett's esophagus: where do we stand? Saudi J Gastroenterol (2009) 0.75
Improved specimen adequacy using jumbo biopsy forceps in patients with Barrett's esophagus. World J Gastroenterol (2015) 0.75
Management controversies in Barrett's oesophagus. J Gastroenterol (2013) 0.75
Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr (2013) 0.75
The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective. Dig Dis Sci (2016) 0.75
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA (2004) 4.71
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Outcomes of planned home births in Washington State: 1989-1996. Obstet Gynecol (2002) 3.99
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
Diabetes and cancer: a consensus report. CA Cancer J Clin (2010) 3.95
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80
Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med (2009) 2.83
Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology (2004) 2.82
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol (2004) 2.55
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf (2008) 2.43
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2007) 2.40
Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int (2004) 2.37
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Recent trials in hypertension: compelling science or commercial speech? JAMA (2006) 2.30
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol (2010) 2.28
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat (2007) 2.27
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology (2012) 2.26
Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg (2009) 2.21
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med (2004) 2.20
Dietary phosphorus is associated with greater left ventricular mass. Kidney Int (2013) 2.19
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med (2008) 2.01
Reporting participation in case-control studies. Epidemiology (2002) 1.99
Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96
A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol (2010) 1.95
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care (2011) 1.83
Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81
The prevalence of knee pain and symptomatic knee osteoarthritis among veteran traumatic amputees and nonamputees. Arch Phys Med Rehabil (2005) 1.81
Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control (2009) 1.79
Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol (2011) 1.78
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77
Association between serum uric acid level and chronic liver disease in the United States. Hepatology (2010) 1.76
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis (2002) 1.72
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood (2002) 1.71
Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med (2013) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Parental smoking and the risk of childhood leukemia. Am J Epidemiol (2006) 1.68
Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med (2014) 1.68
Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol (2012) 1.65
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology (2006) 1.65
Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol (2007) 1.65
Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol Sci (2011) 1.64
Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2009) 1.63
Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med (2012) 1.62
Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.62
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.60
Pregnancy weight gain and risk of neonatal complications: macrosomia, hypoglycemia, and hyperbilirubinemia. Obstet Gynecol (2006) 1.59